Status:
COMPLETED
Effect of Lutein in S-26 Gold On Growth And Safety
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Healthy
Eligibility:
All Genders
Up to 14 years
Phase:
NA
Brief Summary
Study to determine if the addition of lutein to infant formula supports healthy growth and development in healthy full term infants.
Eligibility Criteria
Inclusion
- Healthy infants aged 0-14 days
- Full Term birth and AGA Parent(s) signed informed consent
Exclusion
- Unhealthy infant
- Participation in other clinical trial
- Use of prohibited medications
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
232 Patients enrolled
Trial Details
Trial ID
NCT00913406
Start Date
November 1 2005
End Date
May 1 2006
Last Update
June 4 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.